The incidence of high degree atrioventricular block (HAVB) varies from 2.7 to 14% after acute STEMI. The aim of this study was to evaluate the incidence of high degree atrioventricular block (HAVB) 
INTRODUCTION
Conductions defect is a common complication after acute myocardial infarction. Rate of complications and mortality due to acute ST segment elevation Myocardial Infarction has declined markedly due to the widespread use of various anti-thrombolytic and reperfusion therapies and by the use of recommended preventive drugs. 1, 2 The incidence of high degree atrioventricular block (HAVB) varies from 2.7 to 14% after acute STEMI depending upon the location of wall necrosis and definition of HAVB by various studies. [3] [4] [5] [6] Like other complications of STEMI, the rate of HAVB is also decreasing over time. But the occurrence of HAVB in the acute of myocardial infarction is still associated with a high rate of in-hospital death irrespective of reperfusion therapy used. 7, 8 Thrombolytic therapy is routinely used to prevent mortality in acute phase of myocardial infarction. But its role in preventing the incidence of conduction defects has not been clarified yet.
9
Conduction defects causing severe bradycardia can simply be managed by the use of IV atropine. But complete AV block associated with hemodynamic compromise needs the insertion of temporary pacemaker and in some cases permanent pacemaker is inserted. 10 The aim of this study was to evaluate the incidence of high degree atrioventricular block (HAVB) in patients of acute myocardial infarction presenting in cardiac emergency department of a tertiary care hospital.
PATIENTS AND METHODS
This observational study was conducted in cardiac emergency department of Sheikh Zayed Medical College/Hospital Rahim Yaar Khan. The duration of this study was March 2016 to May 2016. Two hundred patients of acute STEMI was included in this study. Patients of all age groups and gender were included. Patients with history of previous conduction defects, previous cardiac surgery, with advanced stage of heart failure or suffering from renal failure were excluded from this study.
The diagnosis of STEMI was made according to the definition of MI by American heart association task force, and was defined as rise of CKMB levels two times from the baseline value and minimum 1 mm rise in ST segment in two contiguous limb leads or minimum 2 mm rise in ST segment in two contiguous chest leads. Patients suffering from 2 nd degree Mobitz type II or 3 rd degree heart block were labelled as High Degree Atrioventricular Block (HAVB). The diagnosis of heart blocks was based on the findings of standard 12 lead electrocardiogram. The complete disassociation between the atria and ventricular rates, with atrial rate more than ventricular rate was labelled as complete heart block. 2 nd degree Mobitz type II block was identified by intermittent nonconducting P waves not proceeded by PR prolongation or followed by PR shortening.
Detailed history regarding risk factors of coronary artery disease e.g. diabetes, smoking, hypertension and previous family history was taken from the patient or from the attendant of the patient.
Data Analysis was made using Statistical Package for Social Sciences Software V17. Chi-square test was used to compare in-hospital mortality between the groups taking p-value <0.05 as significant difference. High degree atrio-ventricular block was present in 9 (4.5%) patients, out of which 6 (3.0%) patients were presented with Mobitz type II atrio-ventricular block and 3 (1.5%) with complete heart block. Inhospital mortality was significantly high in patients with HAVB, in these patients in-hospital mortality was 2 (22.2%) as compared to only 8 (4.2%) in patients of without HAVB (p-value 0.01). 
RESULTS

DISCUSSION
Like other complications of acute ST segment elevation MI, the incidence of HAVB has also been decreased over the years. 11 But it is still a common complication with incidence varying from 2.7-14.0%. In our study the incidence of HAVB was 4.5%. Gang and colleagues reported that RCA, lesion, advanced age, diabetes and hypertension are important prognosticators for the expansion of HAVB. 4 Patients suffering from HAVB have poor prognostic outcomes and these patients are more likely to develop cardiogenic shock, right venticular infarction, LV dysfunction and ventricular fibrillation.
12 Several studies concluded that HAVB is associated with an increase in in-hospital mortality in the era of thrombolytic and pre-thrombolytic therapy. 8, 13 Various mechanisms responsible for the development HAVB have been proposed which are; activation of parasympathetic nerves in the infero-posterior wall of heart may initiate bradycardia or AV block, 14, 15 AV block may become ischemic in the absence of proper blood supply, however AV node is resistant to ischemia due to its high glycogen reserves but prolonged ischemia with extensive necrosis may result in irreversible injury of AV node. 16, 17 And extensive MI involving inter-ventricular septum may result in bilateral blocks of bundle branches resulting in complete heart block. 18 Consequently site of wall necrosis has a major prognostic implications in patients of MI followed by HAVB. It is also said that there is a high risk of in-hospital mortality due to HAVB in patients suffering from inferior wall MI as compared to the patients with anterior wall MI. 11, 19 In our study, there were two in-hospital deaths in patients of HAVB, one patient was of anterior wall MI and the other of inferior wall MI.
In our study, there were 50.5% patients with anterior wall MI and 12.5% patients were presented with antero-septal MI and there were only 26.5% patients with inferior wall MI. In-hospital mortality was significantly high in patients of HAVB 22.2% versus only 4.2% in patients without HAVB. Auffret et al. also found higher mortality rate in patients with HAVB. In their study, the in-hospital mortality was 17.5% in patients in HAVB and 4.5% in patients without HAVB. 12 Similarly Singh et al and Kim et al also found higher mortality rates in patients of HAVB as compared to patients without HAVB. 7, 20 Our study supported the results of these studies.
